Shaw I C, Graham M I, Jones M S
Arzneimittelforschung. 1986 Mar;36(3):487-9.
[14C]-Mesna (sodium 2-mercaptoethanesulphonate) has a short serum t1/2 (about 16.5 min) and is excreted in the urine. Within 24 h approx. 77% of the administered dose appeared in the urine. It is bound to serum albumin and immunoglobulins. Total serum protein binding is about 9.7% of the total amount present in serum. [14C]-mesna + [14C]-dimesna (bis[2-mercaptoethane sulphonate]) are present in the blood stream, and so are found in the body organs at low concentration, however, localisation of radioactivity occurs in the kidneys. The binding of [14C]-mesna to proteins and the localisation of [14C]-mesna or [14C]-dimesna in the kidneys are discussed in the context of the cell killing efficacy of the oxazaphosphorines.
[¹⁴C] - 美司钠(2 - 巯基乙烷磺酸钠)血清半衰期较短(约16.5分钟),经尿液排泄。在24小时内,约77%的给药剂量出现在尿液中。它与血清白蛋白和免疫球蛋白结合。血清总蛋白结合率约为血清中总量的9.7%。[¹⁴C] - 美司钠 + [¹⁴C] - 二巯基乙烷磺酸钠(双[2 - 巯基乙烷磺酸盐])存在于血流中,因此在体内器官中浓度较低,但放射性在肾脏中定位。在恶唑磷类药物的细胞杀伤效力背景下,讨论了[¹⁴C] - 美司钠与蛋白质的结合以及[¹⁴C] - 美司钠或[¹⁴C] - 二巯基乙烷磺酸钠在肾脏中的定位。